Original Article
An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene
N Engl J Med 2006; 354:1901-1912May 4, 2006
- Abstract
Background
The CD19 protein forms a complex with CD21, CD81, and CD225 in the membrane of mature B cells. Together with the B-cell antigen receptor, this complex signals the B cell to decrease its threshold for activation by the antigen.
Methods
We evaluated four patients from two unrelated families who had increased susceptibility to infection, hypogammaglobulinemia, and normal numbers of mature B cells in blood. We found a mutation in the CD19 gene in all four patients. The CD19 gene in the patients and their first-degree relatives was sequenced, and flow-cytometric immunophenotyping of B cells, immunohistochemical staining of lymphoid tissues, and DNA and messenger RNA analysis were performed. B-cell responses on the triggering of the B-cell receptor were investigated by in vitro stimulation; the antibody response after vaccination with rabies vaccine was also studied.
Results
All four patients had homozygous mutations in the CD19 gene. Levels of CD19 were undetectable in one patient and substantially decreased in the other three. Levels of CD21 were decreased, whereas levels of CD81 and CD225 were normal, in all four patients. The composition of the precursor B-cell compartment in bone marrow and the total numbers of B cells in blood were normal. However, the numbers of CD27+ memory B cells and CD5+ B cells were decreased. Secondary follicles in lymphoid tissues were small to normal in size and had a normal cellular composition. The few B cells that showed molecular signs of switching from one immunoglobulin class to another contained VH-Cα and VH-Cγ transcripts with somatic mutations. The response of the patients' B cells to in vitro stimulation through the B-cell receptor was impaired, and in all four patients, the antibody response to rabies vaccination was poor.
Conclusions
Mutation of the CD19 gene causes a type of hypogammaglobulinemia in which the response of mature B cells to antigenic stimulation is defective.
Media in This Article
Figure 1
Mutations in the CD19 Gene.Figure 2
Immunophenotype of Mature B Cells in Patients with a CD19 Mutation.Article Activity
- Article
Primary antibody deficiencies, which are associated mainly with susceptibility to bacterial infections, can be caused by mutations in genes involved in B-cell differentiation.1 Such genetic defects block the differentiation of immature B cells in bone marrow, thereby causing both a deficiency of mature B cells in the peripheral circulation and agammaglobulinemia.2-8
In disorders involving defects in the maturation process of antigen-responsive B cells, by contrast, there are mature B cells in blood and a deficiency of some, but not all, immunoglobulin classes (dysgammaglobulinemia) or hypogammaglobulinemia. These disorders fall into two categories. The hyper-IgM syndromes are those in which a genetic defect impairs immunoglobulin-class switching (e.g., IgM to IgG) or impairs somatic mutation of immunoglobulin genes (a molecular sign of a response to an antigen), or both.9-12 The second category is common variable immunodeficiency, a syndrome involving hypogammaglobulinemia, recurrent bacterial infections, and a lack of antibody production in response to vaccination. Genetic defects have been found in some patients with common variable immunodeficiency,13,14 but no genetic abnormality is evident in more than 80 percent of such patients.
During B-cell differentiation in the bone marrow, the surface molecule CD19 appears early and remains on the B cell until it differentiates into a plasma cell. Four proteins on the surface of mature B cells — CD19, CD21, CD81, and CD225 — form the CD19 complex, which signals in conjunction with the B-cell antigen receptor, thereby decreasing the threshold for receptor-dependent signaling.15
We describe four patients, from two unrelated families, who had hypogammaglobulinemia and defective CD19. These patients had normal levels of B cells in blood but had undetectable or very low levels of surface CD19, owing to a homozygous mutation in the CD19 gene. The deficiency of antibody in these patients resulted from a subnormal response to antigen by mature B cells.
Case Reports
Patient 1, a girl of Turkish descent and the second child of consanguineous parents (second cousins), was referred to the Selçuk University Hospital in Konya, Turkey, at 10 years of age with a seven-month history of intermittent hematuria. She also had a history of recurrent bronchiolitis and bronchopneumonia starting at one year of age and meningitis starting at eight years of age. On physical examination, her heart rate was 118 beats per minute and auscultation of the lung revealed rhonchi and wheezing. The differential blood count was normal, but urinalysis showed microscopic hematuria without proteinuria. The complement levels were normal, tests for antinuclear antibodies were negative, the erythrocyte sedimentation rate was 41 mm per hour, and the level of C-reactive protein was 93 mg per deciliter. The dermal response to purified protein derivative after two vaccinations with bacille Calmette–Guérin was 12 mm. Renal ultrasonography showed no abnormalities; a renal biopsy revealed proliferation of mesangial cells, interstitial edema, and an apparently normal basement membrane of the glomerulus. She was given a diagnosis of postinfectious glomerulonephritis and was also found to have hypogammaglobulinemia (Table 1Table 1
Baseline Characteristics and Laboratory Findings in Four Patients with CD19 Deficiency.).Patients 2, 3, and 4 were siblings, children of unrelated parents of Colombian descent, and were examined at the Primary Immunodeficiencies Clinic of the University of Antioquia in Medellín, Colombia, at 35, 33, and 49 years of age, respectively. All three had had otitis media, sinusitis, and pharyngitis during childhood. In addition, Patient 2 (the index patient) had had four bouts of pneumonia between the ages of 18 and 35 years; more recently, he had received diagnoses of bacterial conjunctivitis and chronic gastritis (Heliobacter pylori infection). He was given a diagnosis of hypogammaglobulinemia due to common variable immunodeficiency (Table 1). His two sisters also had hypogammaglobulinemia (Table 1) and histories of recurrent upper respiratory tract infections. Patient 3 first had pneumonia at 20 years of age, herpes zoster at 30 years of age, and more recently, recurrent bacterial conjunctivitis with dacryocystitis and diarrhea. Patient 4 had had pneumonia at eight years of age, recurrent skin abscesses and more bouts of pneumonia during childhood, and chronic diarrhea, bronchitis, and recurrent bacterial conjunctivitis during adulthood. These three patients had had surgery for chronic sinusitis.
Intravenous immune globulin therapy was initiated in all four patients soon after the diagnosis of hypogammaglobulinemia. All patients are now clinically well, with no signs of lymphoproliferation, cancer, or autoimmunity. The other siblings of both families have normal serum immunoglobulin levels and no symptoms of immunodeficiency. However, one sibling of Patients 2, 3, and 4 was given a diagnosis of systemic lupus erythematosus at 13 years of age, according to the criteria of the American Rheumatism Association.17
Methods
Diagnostic workups of blood, biopsy of bone marrow, cervical lymph node, and tonsil, and rabies vaccination were carried out in patients and family members after they provided oral informed consent and according to the guidelines of the local medical ethics committees in Turkey, Colombia, and the Netherlands. Controls provided written consent.
Amplification and Sequence Analysis of the CD19 Gene
The CD19 gene on chromosome 16 (16p11.2) spans 7.5 kb of genomic DNA and codes for a protein of 556 amino acids, including the signal peptide.18 DNA was isolated from granulocytes that had been isolated with the use of Ficoll gradient centrifugation. All 15 exons were amplified by the polymerase chain reaction (PCR) (the primer sequences are listed in Part A of the Supplementary Appendix, available with the full text of this article at www.nejm.org) and were sequenced on an ABI Prism 377 fluorescent sequencer (Applied Biosystems).
Total complementary DNA (cDNA) was prepared from messenger RNA (mRNA) that had been isolated from the patients' mononuclear cells, as described previously.19 Fragments of CD19 cDNA were amplified and sequenced to verify the mutations found in the genomic DNA.
CD19 Transcripts
Levels of the CD19 transcript in blood B cells were quantified from reverse-transcribed mRNA from patients' blood mononuclear cells with the use of TaqMan real-time quantitative PCR with newly designed primers and a FAM–TAMRA-labeled fluorogenic probe (sequences are given in Part B of the Supplementary Appendix). The transcript levels were normalized against those of a control ABL gene and corrected for the numbers of B cells as determined by means of flow-cytometric analysis.20
Analysis of Somatic Hypermutation
Hypermutation of immunoglobulin genes was studied in the VH3-Cα, VH4-Cα, VH3-Cγ, and VH4-Cγ fragments, which were amplified from the cDNA and cloned into a pGEM-T easy vector (Promega). Twenty-one clones of Patient 1, 44 clones of Patient 2, 39 clones of Patient 3, and 39 clones of Patient 4 were sequenced. The International ImMunoGeneTics information system (http://imgt.cines.fr/) was used to identify the V, D, and J segments and somatic mutations.21 The ratio of replacement and silent mutations was determined for the framework regions and the complementarity-determining regions, and the distribution of replacement mutations in the framework regions was analyzed according to the binomial distribution model of Chang and Casali.22
Flow Cytometry
Flow-cytometric immunophenotyping of blood samples from four patients, nine relatives (including eight carriers), and eight controls was performed to evaluate markers and subgroups of B cells. We also analyzed bone marrow samples from Patient 1 and from five controls, as previously described.23 Antibodies against CD21 (LB21), CD81 (JS-81), and CD225 (Leu13) were used to analyze the CD19 complex further.15,24
Western Blotting
B cells in blood were sorted from mononuclear cells with the use of the magnetic affinity cell-sorting B-cell purification kit (Miltenyi Biotec). Lysates of B cells (2×106) were separated by sodium dodecyl sulfate–polyacrylamide-gel electrophoresis and immunoblotted with the use of a polyclonal rabbit antiserum against the intracellular portion of human CD19.25
Histology and Immunohistochemistry
The biopsy specimen of a cervical lymph node from Patient 1 and the tonsil-biopsy specimen from Patient 2 were fixed in formalin, embedded in paraffin, and stained with hematoxylin and eosin. Immunohistochemistry was performed according to standard procedures involving monoclonal antibodies against CD20 (L26), CD21 (1F8), CD79a (JCB117), BCL-2 (124), BCL-6 (PG-B6p), and Ki67 (MIB-1), all obtained from DakoCytomation.
B-Cell Activation
Blood mononuclear cells were incubated with 6 μg of indo-1 per milliliter of cell suspension (Molecular Probes) to evaluate calcium fluxes after stimulation. Levels of free intracellular calcium were measured in CD20+ B cells with the use of flow cytometry in a FACSVantage station (BD Biosciences) before and after stimulation with Staphylococcus aureus Cowan I (Calbiochem) in a 1:500 dilution or with 20 μg of goat antihuman IgM F(ab')2 per milliliter (Jackson Immunoresearch Laboratories). Subsequently, 2 μg of ionomycin per milliliter (Molecular Probes) was added to control for intracellular loading of indo-1.
B-Cell Proliferation
Enriched blood B cells (1×105 per well) were cultured in 96-well flat-bottomed plates for 48 or 72 hours at 37°C and stimulated with S. aureus Cowan I in a 1:10,000 dilution or with 20 μg of anti-IgM F(ab')2 per milliliter. Proliferation of the B cells was assessed by incorporating 0.5 μCi of [3H]thymidine in each well.
In Vivo Vaccination with Rabies Vaccine
Patients, relatives, and controls were vaccinated twice with the human diploid-cell rabies vaccine (Institut Pasteur Merieux, Merck Sharp & Dohme) according to standard protocols. Antibody levels and avidity were measured as previously described.26
Results
Identification of CD19 Defects
Flow-cytometric immunophenotyping with antibodies against the cell-surface markers CD3 (on T cells), CD16 or CD56 or both (on natural killer cells), and CD19 or CD20 (on B cells) results in the identification of more than 95 percent of lymphocytes. All four patients had normal absolute numbers of CD20+ B cells. In contrast, membrane expression of CD19 on B cells was not detectable in Patient 1 and was barely detectable in Patients 2, 3, and 4 (Figure 1AFigure 1
Mutations in the CD19 Gene.).Sequencing of the CD19 gene in Patient 1 revealed an insertion of an adenine in exon 6 of both alleles of CD19. This insertion causes a frame shift, and thus there is a premature stop codon at the intracellular amino acid 328 (Figure 1B). Patients 2, 3, and 4 were homozygous for a dinucleotide deletion of guanine and adenine in exon 11, resulting in a premature stop codon at the intracellular amino acid 465 (Figure 1B). Living parents and several members of both families carried one mutated allele (Figure 1C and 1D) but had no clinical features of immunodeficiency.
Normal levels of CD19 transcripts were found in B cells from all patients (data not shown). Western blotting did not detect the CD19 protein in B cells from Patient 1, because the CD19 in this patient lacked most of the cytoplasmic domains. However, a reduction in intracellular levels of CD19 was observed in B cells from Patient 4 (data not shown), confirming the flow-cytometric results.
Membrane Expression of the CD19 Complex
The level of expression of CD19 in the carriers of the mutations was lower than that in controls (Figure 2AFigure 2
Immunophenotype of Mature B Cells in Patients with a CD19 Mutation.). In addition, CD21 expression on the surface of patients' B cells was also reduced (Figure 2B). CD81 and CD225 molecules were expressed at normal levels by the B cells of all patients and carriers (data not shown).B-Cell Differentiation
The precursor B-cell compartment in the bone marrow of Patient 1 showed a normal relative distribution of all differentiation stages (data not shown).23 Ig-κ+ B cells and Ig-λ+ B cells were present in normal ratios in blood samples from all patients. Moreover, B cells from all four patients had normal expression of other membrane-bound molecules, including IgM, IgD, CD20, CD22, CD38, CD40, beta2-microglobulin, and HLA-DR. However, all four patients had decreased levels of CD5+ B cells (8 to 12 percent) and CD27+ memory B cells (1 to 6 percent) in blood, as compared with levels in age-matched controls and carriers (19 to 41 percent for CD5+ and 17 to 28 percent for CD27+) (Figure 2C and 2D). Memory B cells that switched immunoglobulin class were CD27+IgD−, lacking IgM and IgD, and were present in decreased numbers in blood samples from all patients. Sequencing of the VH-Cα and VH-Cγ transcripts showed somatic hypermutations in a pattern suggesting the potential to produce an antigen-selected B-cell–receptor repertoire, which is a molecular sign of a response to antigenic stimulation (data not shown).
The numbers of CD27+ memory B cells in carriers in the family of Patient 1 were similar to those in controls, whereas carriers in the family of Patients 2, 3, and 4 had fewer memory B cells than controls (Figure 2D). In general, however, in contrast to the patients, the carriers in the family of Patients 2, 3, and 4 had mainly memory B cells that had switched immunoglobulin class and normal serum immunoglobulin levels (data not shown).
Germinal Centers in Secondary Lymphoid Organs
Histologic analysis of a sample of cervical lymph node from Patient 1 showed multiple B-cell follicles of small-to-moderate size with proliferation centers on immunohistochemical staining for CD79a, BCL-2, BCL-6, CD21, and Ki67 (Figure 3AFigure 3
Normal Formation of the Germinal Center.). Follicles of normal size and architecture were also found in the tonsil specimen from Patient 2 (Figure 3B).Calcium Mobilization and Proliferation on Stimulation of the B-Cell Receptor
B-cell receptor–mediated activation causes an initial flux of calcium from the rough endoplasmic reticulum into the cytoplasm, followed by a sustained influx of extracellular calcium.27 As compared with control B cells, the B cells from all four patients with CD19 deficiency exhibited defective calcium fluxes after stimulation with an anti-IgM antibody, which cross-links IgM molecules on the B-cell surface. No calcium influx or efflux was observed in the B cells from Patient 1, whereas the initial calcium influx was delayed in B cells from Patients 2, 3, and 4. Furthermore, calcium efflux in all four patients was delayed and remained low for the duration of the experiment (Figure 4AFigure 4
In Vitro Responses of B Cells and Antibody Responses to Rabies Vaccine.; data for Patients 2 and 3 not shown). B cells from heterozygous relatives had normal calcium fluxes (data not shown). Normal calcium fluxes were found in Patients 2, 3, and 4 in response to S. aureus Cowan I, which activates B cells by means of innate immune receptors and the B-cell receptor (data not shown).B cells from Patient 1 proliferated poorly after stimulation with S. aureus Cowan I or an anti-IgM antibody, as compared with B cells from the control (Figure 4B). B cells from the parents of Patient 1, who are carriers of the mutation, showed intermediate proliferation in response to both S. aureus Cowan I and anti-IgM antibody (Figure 4B). B cells from carriers in the family of Patients 2, 3, and 4 proliferated normally after stimulation with S. aureus Cowan I or anti-IgM antibody (not shown).
Antibody Response to Rabies Vaccine
To test the primary and secondary antibody responses in vivo, all patients were vaccinated twice with rabies vaccine (at week 0 and week 13). The primary response of production of IgG anti-rabies antibody in Patient 1 was low but detectable, whereas Patients 2, 3, and 4 did produce IgG anti-rabies antibodies after the first vaccination. The secondary IgG response, after week 13, in all patients was below the 95 percent confidence interval of the normal response (Figure 4C).26 Furthermore, no increase in avidity was observed in Patient 2, 3, or 4, and Patient 1 had only a marginal increase in avidity during the secondary response (Figure 4D). The second antibody response and the increase in avidity maturation were normal in the two carriers evaluated in the family of Patients 2, 3, and 4 (Figure 4C and 4D).
Discussion
We described four patients (from two different families) with homozygous mutations in CD19 and showed that their profound hypogammaglobulinemia resulted from a poor response to antigen by mature B cells. Both CD19 mutations were frameshift mutations, causing premature stop codons that result in the deletion of the total cytoplasmic domain (in the family of Patient 1) or a major part of the cytoplasmic domain (in family B). Both truncations result in the lack of the three C-terminal tyrosine residues, two of which have been shown to be critical for signal transduction through CD19 (Figure 1B).25
These mutations are not likely to be polymorphisms; CD19 is the most broadly used B-cell marker for flow-cytometric immunophenotyping of lymphocytes and has not been found to be lacking in large-scale studies of healthy children.16,28 Moreover, the B cells of heterozygous carriers of the mutation expressed CD19, albeit at slightly lower levels than noncarriers. Futhermore, CD19 — together with CD21, CD81, and CD225 — forms a signaling complex that decreases the threshold for the activation of B cells as mediated by the B-cell receptor.29
B cells from CD81-knockout mice have decreased CD19 expression.30,31 The mature B cells from our patients, however, had a normal level of expression of CD81 and CD225 but a reduced level of expression of CD21, suggesting a dependency of CD21 on CD19. Normal levels of CD19 transcripts in the B cells of these patients indicate that the reduction in the level of the protein does not result from nonsense-mediated decay of mRNA, but rather from the instability of the truncated CD19 proteins. This interpretation is consistent with the observation that truncated (but otherwise stable) CD19 molecules can associate with CD81 and CD225 on the membranes of B cells in which 95 percent of the cytoplasmic domains of CD19 are deleted.32
The CD19 deficiency did not disturb the differentiation of precursor B cells in the bone marrow. Still, CD19-deficient B cells may undergo differentiation less efficiently than CD19+ B cells, as has been observed in CD19-knockout mice.33,34 Nevertheless, our patients had normal numbers of mature B cells in blood.
The numbers of CD5+ B cells in our patients were decreased, as they are in CD19-knockout mice.35,36 CD5 is a negative regulator of B-cell receptor signaling, and in mice, this marker defines the subgroup of autoreactive B-1a cells.37,38 It is likely that, in our patients, the inhibitory effect of CD5 on B-cell–receptor signaling is superfluous in the absence of CD19.
The numbers of CD27+IgD+ and CD27+IgD− memory B cells in blood from all four patients were decreased. Together with the finding of decreased serum immunoglobulin levels, this finding suggests that terminal differentiation of B cells into memory B cells and plasma cells is affected. In two patients, secondary lymphoid tissues contained follicles of small-to-moderate size with germinal centers that appeared normal. CD19-knockout mice lack germinal centers, but centers appear when the animals are challenged with live virus.39 IgG antibodies and circulating memory B cells are defective in these mice,39 as they are in our four patients.
IgG and IgA transcripts with antigen-driven hypermutation were found in our patients at variable levels, indicating that CD19-deficient B cells are in principle able to undergo antigen-dependent differentiation, albeit with reduced efficiency. In mice, defects in CD19 signaling due to mutations in critical intracellular tyrosines result in the absence of high-affinity antibodies owing to low B-cell proliferation and abnormal immunoglobulin-class switching.25,40,41
The inefficient response of CD19-deficient B cells in these patients probably results from the loss of dual antigen recognition through the B-cell receptor and the CD19 complex.15,42 The B cells from all four patients had abnormal calcium fluxes on stimulation, but the differences between Patient 1 and the other three patients may be due to the presence of different mutations. Patient 1 lacked all the intracellular domains responsible for signal transduction32; in Patients 2, 3, and 4, the CD19 molecule lacked only 92 amino acids at the intracellular C-terminal end, which contains two critical tyrosines that are required for most functions of CD19.25 Most of the intracellular domains were present, potentially permitting some B-cell signaling.43 Nevertheless, all four patients with CD19 deficiency had substantially decreased antibody responses (levels and avidity) after vaccination with rabies vaccine. We conclude that the CD19 signals that normally enable B-cell responses to antigenic stimuli are lacking in our patients.
This study shows that the disruption of CD19 signaling results in a primary antibody deficiency, mainly characterized by a poor antigen-specific response. On the basis of the crucial role of CD19 in signaling by the B-cell receptor on antigen recognition, it is likely that defects in other members of the CD19 complex (CD21, CD81, and CD225) also lead to antibody deficiency in humans.
Supported by grants from Sophia Kinderziekenhuis Fonds (349), Revolving Fund 2000, the Vereniging Trustfonds Erasmus Universiteit Rotterdam, the Colombian Institute for Scientific and Technological Development (Colciencias; 1115-04-11924 and 1115-05-16874), and the Deutsche Forschungsgemeinschaft (GR1617/3 and SFB620). No potential conflict of interest relevant to this article was reported.
Mr. van Zelm, Dr. Reisli, Dr. van der Burg, and Ms. Castaño contributed equally to the article.
We are indebted to Mrs. B.H. Barendregt, Mrs. S. de Bruin-Versteeg, and Mr. E.F.E. de Haas for their support with flow-cytometric immunophenotyping and functional assays; to S. Evans, Rockwell Park Institute, for the antihuman CD225; to R. Carter, University of Alabama at Birmingham, for the polyclonal rabbit anti-CD19 antiserum; to Mrs. C.M. Jol-van der Zijde for performing the serologic antirabies response experiments; to Ms. C. Rubeles and Mrs. B. Vieco, Dr. C. Montoya, Dr. M. Schlesier, Dr. U. Salzer, and Mrs. D. Thiel for their technical assistance; to Dr. H. Arbag and Dr. M. Cihat Avunduk for their support in the diagnostic procedures; and to Mrs. W.M. Comans-Bitter for assistance with the figures.
Source Information
From the Department of Immunology, Erasmus MC (M.C.Z., M.B., J.J.M.D.), and the Department of Pediatrics, Erasmus MC–Sophia (M.C.Z.), Rotterdam, the Netherlands; the Department of Pediatric Immunology and Allergy, Meram Medical Faculty, Selçuk University, Konya, Turkey (I.R.); the Group of Primary Immunodeficiencies, University of Antioquia, Medellín, Colombia (D.C., P.J.P., J.L.F.); the Department of Pathology, Academic Medical Center, Amsterdam (C.J.M.N.); the Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands (M.J.D.T.); and the Division of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany (C.W., B.G.).
Address reprint requests to Dr. van Dongen at the Department of Immunology, Molecular Immunology Unit, Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, the Netherlands, or at j.j.m.vandongen@erasmusmc.nl.
- References
References
1
Ballow M . Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 2002;109:581-591
CrossRef | Web of Science | Medline2
Vetrie D ,Vorechovsky I ,Sideras P , et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993;361:226-233[Erratum, Nature 1993;364:362.]
CrossRef | Web of Science | Medline3
Tsukada S ,Saffran DC ,Rawlings DJ , et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-290
CrossRef | Web of Science | Medline4
Yel L ,Minegishi Y ,Coustan-Smith E , et al. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 1996;335:1486-1493
Full Text | Web of Science | Medline5
Minegishi Y ,Coustan-Smith E ,Wang YH ,Cooper MD ,Campana D ,Conley ME . Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 1998;187:71-77
CrossRef | Web of Science | Medline6
Minegishi Y ,Coustan-Smith E ,Rapalus L ,Ersoy F ,Campana D ,Conley ME . Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest 1999;104:1115-1121
CrossRef | Web of Science | Medline7
Minegishi Y ,Rohrer J ,Coustan-Smith E , et al. An essential role for BLNK in human B cell development. Science 1999;286:1954-1957
CrossRef | Web of Science | Medline8
Conley ME ,Rohrer J ,Rapalus L ,Boylin EC ,Minegishi Y . Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol Rev 2000;178:75-90
CrossRef | Web of Science | Medline9
Allen RC ,Armitage RJ ,Conley ME , et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-993
CrossRef | Web of Science | Medline10
Revy P ,Muto T ,Levy Y , et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 2000;102:565-575
CrossRef | Web of Science | Medline11
Ferrari S ,Giliani S ,Insalaco A , et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 2001;98:12614-12619
CrossRef | Web of Science | Medline12
Imai K ,Slupphaug G ,Lee WI , et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 2003;4:1023-1028
CrossRef | Web of Science | Medline13
Grimbacher B ,Hutloff A ,Schlesier M , et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003;4:261-268
CrossRef | Web of Science | Medline14
Salzer U ,Chapel HM ,Webster AD , et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005;37:820-828
CrossRef | Web of Science | Medline15
Carter RH ,Fearon DT . CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992;256:105-107
CrossRef | Web of Science | Medline16
Comans-Bitter WM ,de Groot R ,van den Beemd R , et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-393
CrossRef | Web of Science | Medline17
Amett FC ,Edworthy SM ,Bloch DA , et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
CrossRef | Web of Science | Medline18
Tedder TF ,Isaacs CM . Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: a new member of the immunoglobulin superfamily. J Immunol 1989;143:712-717
Web of Science | Medline19
van Dongen JJ ,Macintyre EA ,Gabert JA , et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease: report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901-1928
CrossRef | Web of Science | Medline20
Beillard E ,Pallisgaard N ,van der Velden VH , et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using `real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) -- a Europe against Cancer program. Leukemia 2003;17:2474-2486
CrossRef | Web of Science | Medline21
Lefranc MP . IMGT databases, Web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr. Leukemia 2003;17:260-266
CrossRef | Web of Science | Medline22
Chang B ,Casali P . The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994;15:367-373
CrossRef | Medline23
Noordzij JG ,de Bruin-Versteeg S ,Verkaik NS , et al. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. Blood 2002;100:2145-2152
Web of Science | Medline24
Evans SS ,Lee DB ,Han T ,Tomasi TB ,Evans RL . Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 1990;76:2583-2593
Web of Science | Medline25
Wang Y ,Brooks SR ,Li X ,Anzelon AN ,Rickert RC ,Carter RH . The physiologic role of CD19 cytoplasmic tyrosines. Immunity 2002;17:501-514
CrossRef | Web of Science | Medline26
Brinkman DM ,Jol-van der Zijde CM ,ten Dam MM , et al. Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man. J Clin Immunol 2003;23:528-538
CrossRef | Web of Science | Medline27
Scharenberg AM ,Kinet JP . PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell 1998;94:5-8
CrossRef | Web of Science | Medline28
Ikinciogullari A ,Kendirli T ,Dogu F , et al. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr 2004;46:125-130
Web of Science | Medline29
Bradbury LE ,Kansas GS ,Levy S ,Evans RL ,Tedder TF . The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 1992;149:2841-2850
Web of Science | Medline30
Maecker HT ,Levy S . Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med 1997;185:1505-1510
CrossRef | Web of Science | Medline31
Shoham T ,Rajapaksa R ,Boucheix C , et al. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J Immunol 2003;171:4062-4072
Web of Science | Medline32
Bradbury LE ,Goldmacher VS ,Tedder TF . The CD19 signal transduction complex of B lymphocytes: deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J Immunol 1993;151:2915-2927
Web of Science | Medline33
Otero DC ,Rickert RC . CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition. J Immunol 2003;171:5921-5930
Web of Science | Medline34
Diamant E ,Keren Z ,Melamed D . CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing. Blood 2005;105:3247-3254
CrossRef | Web of Science | Medline35
Rickert RC ,Rajewsky K ,Roes J . Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995;376:352-355
CrossRef | Web of Science | Medline36
Engel P ,Zhou LJ ,Ord DC ,Sato S ,Koller B ,Tedder TF . Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995;3:39-50
CrossRef | Web of Science | Medline37
Gary-Gouy H ,Bruhns P ,Schmitt C ,Dalloul A ,Daeron M ,Bismuth G . The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem 2000;275:548-556
CrossRef | Web of Science | Medline38
Berland R ,Wortis HH . Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002;20:253-300
CrossRef | Web of Science | Medline39
Fehr T ,Rickert RC ,Odermatt B , et al. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J Exp Med 1998;188:145-155
CrossRef | Web of Science | Medline40
Wang Y ,Carter RH . CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity 2005;22:749-761
CrossRef | Web of Science | Medline41
Barrington RA ,Zhang M ,Zhong X , et al. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J Immunol 2005;175:2859-2867
Web of Science | Medline42
van Noesel CJ ,Lankester AC ,van Lier RA . Dual antigen recognition by B cells. Immunol Today 1993;14:8-11
CrossRef | Medline43
Brooks SR ,Kirkham PM ,Freeberg L ,Carter RH . Binding of cytoplasmic proteins to the CD19 intracellular domain is high affinity, competitive, and multimeric. J Immunol 2004;172:7556-7564
Web of Science | Medline
- Citing Articles (119)
Citing Articles
1
Ulrich Salzer, Susanne Unger, Klaus Warnatz. (2012) Common variable immunodeficiency (CVID): exploring the multiple dimensions of a heterogeneous disease. Annals of the New York Academy of Sciencesno-no
CrossRef2
Ombrello, Michael J., Remmers, Elaine F., Sun, Guangping, Freeman, Alexandra F., Datta, Shrimati, Torabi-Parizi, Parizad, Subramanian, Naeha, Bunney, Tom D., Baxendale, Rhona W., Martins, Marta S., Romberg, Neil, Komarow, Hirsh, Aksentijevich, Ivona, Kim, Hun Sik, Ho, Jason, Cruse, Glenn, Jung, Mi-Yeon, Gilfillan, Alasdair M., Metcalfe, Dean D., Nelson, Celeste, O'Brien, Michelle, Wisch, Laura, Stone, Kelly, Douek, Daniel C., Gandhi, Chhavi, Wanderer, Alan A., Lee, Hane, Nelson, Stanley F., Shianna, Kevin V., Cirulli, Elizabeth T., Goldstein, David B., Long, Eric O., Moir, Susan, Meffre, Eric, Holland, Steven M., Kastner, Daniel L., Katan, Matilda, Hoffman, Hal M., Milner, Joshua D., . (2012) Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions. New England Journal of Medicine 366:4, 330-338
Full Text3
Michael M. Frank. (2012) CD21 deficiency, complement, and the development of common variable immunodeficiency. Journal of Allergy and Clinical Immunology
CrossRef4
Stuart G. Tangye, Elissa K. Deenick, Umaimainthan Palendira, Cindy S. Ma. (2012) T cell-B cell interactions in primary immunodeficiencies. Annals of the New York Academy of Sciencesno-no
CrossRef5
Vassilios Lougaris, Manuela Baronio, Massimiliano Vitali, Giacomo Tampella, Annarosa Soresina, Raffaele Badolato, Alessandro Plebani. (2012) B Cell Responses to CpG Correlate with CXCL16 Expression Levels in Common Variable Immunodeficiency. The Scientific World Journal 2012, 1-9
CrossRef6
Joon H. Park, Elena S. Resnick, Charlotte Cunningham-Rundles. (2011) Perspectives on common variable immune deficiency. Annals of the New York Academy of Sciences 1246:1, 41-49
CrossRef7
Magdalena A. Berkowska, Mirjam van der Burg, Jacques J.M. van Dongen, Menno C. van Zelm. (2011) Checkpoints of B cell differentiation: visualizing Ig-centric processes. Annals of the New York Academy of Sciences 1246:1, 11-25
CrossRef8
María B. Almejún, Elisa Sajaroff, Miguel Galicchio, Matías Oleastro, Andrea Bernasconi, Marta Zelazko, Silvia Danielian. (2011) Immunological Characteristics and Two Novel Mutations in TACI in a Cohort of 28 Pediatric Patients with Common Variable Immunodeficiency. Journal of Clinical Immunology
CrossRef9
E. J. H. Schatorjé, E. F. A. Gemen, G. J. A. Driessen, J. Leuvenink, R. W. N. M. van Hout, M. van der Burg, E. de Vries. (2011) Age-matched Reference Values for B-lymphocyte Subpopulations and CVID Classifications in Children. Scandinavian Journal of Immunology 74:5, 502-510
CrossRef10
Annick A.J.M. van de Ven, Ewoud B. Compeer, Andries C. Bloem, Lisette van de Corput, Marielle van Gijn, Joris M. van Montfrans, Marianne Boes. (2011) Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders. Journal of Allergy and Clinical Immunology
CrossRef11
Ozden Sanal, Ilhan Tezcan. (2011) Thirty years of primary immunodeficiencies in Turkey. Annals of the New York Academy of Sciences 1238:1, 15-23
CrossRef12
Rohan Ameratunga, See-Tarn Woon, Maia Brewerton, Wikke Koopmans, Anthony Jordan, Shannon Brothers, Ranjeeta Singh. (2011) Primary immune deficiency disorders in the South Pacific: the clinical utility of a customized genetic testing program in New Zealand. Annals of the New York Academy of Sciences 1238:1, 53-64
CrossRef13
Mirjam Burg, Menno C. Zelm, Gertjan J. A. Driessen, Jacques J. M. Dongen. (2011) New frontiers of primary antibody deficiencies. Cellular and Molecular Life Sciences
CrossRef14
G. J. Driessen, M. C. van Zelm, P. M. van Hagen, N. G. Hartwig, M. Trip, A. Warris, E. de Vries, B. H. Barendregt, I. Pico, W. Hop, J. J. M. van Dongen, M. van der Burg. (2011) B-cell replication history and somatic hypermutation status identify distinct pathophysiological backgrounds in common variable immunodeficiency. Blood
CrossRef15
, Claire Rivoisy, Laurence Gérard, David Boutboul, Marion Malphettes, Claire Fieschi, Isabelle Durieu, François Tron, Agathe Masseau, Pierre Bordigoni, Laurent Alric, Julien Haroche, Cyrille Hoarau, Alice Bérézné, Maryvonnick Carmagnat, Gael Mouillot, Eric Oksenhendler. (2011) Parental Consanguinity is Associated with a Severe Phenotype in Common Variable Immunodeficiency. Journal of Clinical Immunology
CrossRef16
Hong-Ying Wang, Ashish Jain. (2011) Novel Sequencing-based Strategies for High-Throughput Discovery of Genetic Mutations Underlying Inherited Antibody Deficiency Disorders. Current Allergy and Asthma Reports 11:5, 352-360
CrossRef17
Jens Thiel, Lucas Kimmig, Ulrich Salzer, Magdalena Grudzien, Dirk Lebrecht, Tina Hagena, Ruth Draeger, Nadine Völxen, Astrid Bergbreiter, Stephanie Jennings, Sylvia Gutenberger, Annette Aichem, Harald Illges, Jonathan P. Hannan, Anne-Kathrin Kienzler, Marta Rizzi, Hermann Eibel, Hans-Hartmut Peter, Klaus Warnatz, Bodo Grimbacher, Jörg-Andres Rump, Michael Schlesier. (2011) Genetic CD21 deficiency is associated with hypogammaglobulinemia. Journal of Allergy and Clinical Immunology
CrossRef18
Yoshihiro Baba, Tomohiro Kurosaki. (2011) Impact of Ca2+ signaling on B cell function. Trends in Immunology
CrossRef19
Federico Serana, Paolo Airò, Marco Chiarini, Cinzia Zanotti, Mirko Scarsi, Micol Frassi, Vassilios Lougaris, Alessandro Plebani, Luigi Caimi, Luisa Imberti. (2011) Thymic and Bone Marrow Output in Patients with Common Variable Immunodeficiency. Journal of Clinical Immunology 31:4, 540-549
CrossRef20
Gertjan Driessen, Mirjam Burg. (2011) Educational paper. European Journal of Pediatrics 170:6, 693-702
CrossRef21
Jordan S. Orange, Joseph T. Glessner, Elena Resnick, Kathleen E. Sullivan, Mary Lucas, Berne Ferry, Cecilia E. Kim, Cuiping Hou, Fengxiang Wang, Rosetta Chiavacci, Subra Kugathasan, John W. Sleasman, Robert Baldassano, Elena E. Perez, Helen Chapel, Charlotte Cunningham-Rundles, Hakon Hakonarson. (2011) Genome-wide association identifies diverse causes of common variable immunodeficiency. Journal of Allergy and Clinical Immunology 127:6, 1360-1367.e6
CrossRef22
Nima Rezaei, Mona Hedayat, Asghar Aghamohammadi, Kim E. Nichols. (2011) Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. Journal of Allergy and Clinical Immunology 127:6, 1329-1341.e2
CrossRef23
Zita Chovancova, Marcela Vlkova, Jiri Litzman, Jindrich Lokaj, Vojtech Thon. (2011) Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. Vaccine 29:24, 4142-4150
CrossRef24
H. Bernuth, K. Schwarz, E.D. Renner, S. Ehl. (2011) Diagnostik primärer Immundefekte. Monatsschrift Kinderheilkunde 159:5, 434-442
CrossRef25
M. C. van Zelm, J. Smet, M. van der Burg, A. Ferster, P. Q. Le, L. Schandene, J. J. M. van Dongen, F. Mascart. (2011) Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation. Human Molecular Genetics 20:9, 1854-1863
CrossRef26
Maite Torres-Salido, Josefina Cortés-Hernández, Eva Balada, Miquel Vilardell Tarrés, Josep Ordi-Ros. (2011) Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms. Rheumatology International 31:4, 537-541
CrossRef27
Fatih M. Uckun, Lei Sun, Sanjive Qazi, Hong Ma, Zahide Ozer. (2011) Recombinant human CD19-ligand protein as a potent anti-leukaemic agent. British Journal of Haematology 153:1, 15-23
CrossRef28
J. Smet, F. Mascart, L. Schandené. (2011) Are the reference values of B cell subpopulations used in adults for classification of common variable immunodeficiencies appropriate for children?. Clinical Immunology 138:3, 266-273
CrossRef29
Julien Boileau, Gael Mouillot, Laurence Gérard, Maryvonnick Carmagnat, Claire Rabian, Eric Oksenhendler, Jean-Louis Pasquali, Anne-Sophie Korganow. (2011) Autoimmunity in common variable immunodeficiency: Correlation with lymphocyte phenotype in the French DEFI study. Journal of Autoimmunity 36:1, 25-32
CrossRef30
Elena López, Isabel López, Antonio Ferreira, Julia Sequí. (2011) Clinical and Technical Phosphoproteomic Research. Proteome Science 9:1, 27
CrossRef31
Patrick F.K. Yong, James E.D. Thaventhiran, Bodo Grimbacher. 2011. “A Rose is a Rose is a Rose,” but CVID is Not CVID. , 47-107.
CrossRef32
Giuseppe Spadaro, Concetta D'Orio, Arturo Genovese, Antonella Galeotafiore, Chiara D'Ambrosio, Stefano Di Giovanni, Monica Vitale, Mario Capasso, Vincenzo Lamberti, Andrea Scaloni, Gianni Marone, Nicola Zambrano. (2011) Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy. Journal of Biomedicine and Biotechnology 2011, 1-10
CrossRef33
Nico M. Wulffraat, Joris van Montfrans, Wietse Kuis. 2011. IMMUNODEFICIENCIES AND THE RHEUMATIC DISEASES. , 627-641.
CrossRef34
Julie Smet, Menno van Zelm, Liliane Schandené, Brigitte Adams, Mirjam van der Burg, Françoise Mascart. (2011) Rôle de la molécule CD81 dans le fonctionnement des lymphocytes B chez l’homme. médecine/sciences 27:1, 33-35
CrossRef35
Hermann Eibel, Ulrich Salzer, Klaus Warnatz. (2010) Common variable immunodeficiency at the end of a prospering decade: towards novel gene defects and beyond. Current Opinion in Allergy and Clinical Immunology 10:6, 526-533
CrossRef36
Daniel J.B. Marks, Craig R. Seymour, Gavin W. Sewell, Farooq Z. Rahman, Andrew M. Smith, Sara A. McCartney, Stuart L. Bloom. (2010) Inflammatory bowel diseases in patients with adaptive and complement immunodeficiency disorders. Inflammatory Bowel Diseases 16:11, 1984-1992
CrossRef37
Joao B. Oliveira, Thomas A. Fleisher. (2010) Molecular- and Flow Cytometry-based Diagnosis of Primary Immunodeficiency Disorders. Current Allergy and Asthma Reports 10:6, 460-467
CrossRef38
Barbara Piątosa, Beata Wolska-Kuśnierz, Małgorzata Pac, Katarzyna Siewiera, Ewa Gałkowska, Ewa Bernatowska. (2010) B cell subsets in healthy children: Reference values for evaluation of B cell maturation process in peripheral blood. Cytometry Part B: Clinical Cytometry 78B:6, 372-381
CrossRef39
Georgia Malamut, Virginie Verkarre, Felipe Suarez, Jean-François Viallard, Anne-Sophie Lascaux, Jacques Cosnes, Yoram Bouhnik, Olivier Lambotte, Dominique Béchade, Marianne Ziol, Anne Lavergne, Olivier Hermine, Nadine Cerf-Bensussan, Christophe Cellier. (2010) The Enteropathy Associated With Common Variable Immunodeficiency: The Delineated Frontiers With Celiac Disease. The American Journal of Gastroenterology 105:10, 2262-2275
CrossRef40
H Artac, I Reisli, R Kara, I Pico-Knijnenburg, S Adin-Çinar, S Pekcan, C M Jol-van der Zijde, M J D van Tol, L E Bakker-Jonges, J J M van Dongen, M van der Burg, M C van Zelm. (2010) B-cell maturation and antibody responses in individuals carrying a mutated CD19 allele. Genes and Immunity 11:7, 523-530
CrossRef41
Hong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, Meredith Yeager, Chi Adrian Ma, Yasmin Ali Mohamoud, Mariam Quinones, Casey Matthews, Joseph Boland, Julie E. Niemela, Troy R. Torgerson, Silvia Giliani, Gulbu Uzel, Jordan S. Orange, Ralph Shapiro, Luigi Notarangelo, Hans D. Ochs, Thomas Fleisher, Daniel Kastner, Stephen J. Chanock, Ashish Jain. (2010) A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiency. Human Mutation 31:9, 1080-1088
CrossRef42
Tomohiro Kurosaki, Yuichi Aiba, Kohei Kometani, Saya Moriyama, Yoshimasa Takahashi. (2010) Unique properties of memory B cells of different isotypes. Immunological Reviews 237:1, 104-116
CrossRef43
Katrina L Randall. (2010) Generating humoral immune memory following infection or vaccination. Expert Review of Vaccines 9:9, 1083-1093
CrossRef44
Y Y Ng, M R M Baert, K Pike-Overzet, M Rodijk, M H Brugman, A Schambach, C Baum, R W Hendriks, J J M van Dongen, F J T Staal. (2010) Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK. Leukemia 24:9, 1617-1630
CrossRef45
Facundo D. Batista, Bebhinn Treanor, Naomi E. Harwood. (2010) Visualizing a role for the actin cytoskeleton in the regulation of B-cell activation. Immunological Reviews 237:1, 191-204
CrossRef46
T. Freiberger, L. Grodecká, B. Ravčuková, B. Kuřecová, V. Postránecká, J. Vlček, J. Jarkovský, V. Thon, J. Litzman. (2010) Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency. Clinical Immunology 136:3, 419-425
CrossRef47
Santi Suryani, Stuart G Tangye. (2010) Therapeutic implications of advances in our understanding of transitional B-cell development in humans. Expert Review of Clinical Immunology 6:5, 765-775
CrossRef48
Christopher C Goodnow, Carola G Vinuesa, Katrina L Randall, Fabienne Mackay, Robert Brink. (2010) Control systems and decision making for antibody production. Nature Immunology 11:8, 681-688
CrossRef49
Pierre L. Yong, Jordan S. Orange, Kathleen E. Sullivan. (2010) Pediatric common variable immunodeficiency: Immunologic and phenotypic associations with switched memory B cells. Pediatric Allergy and Immunology 21:5, 852-858
CrossRef50
Katharine S Nelson, David B Lewis. (2010) Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves. Current Opinion in Infectious Diseases 23:4, 359-364
CrossRef51
C. Cunningham-Rundles. (2010) How I treat common variable immune deficiency. Blood 116:1, 7-15
CrossRef52
Anne-Sophie Korganow, Anne-Marie Knapp, Hélène Nehme-Schuster, Pauline Soulas-Sprauel, Vincent Poindron, Jean-Louis Pasquali, Thierry Martin. (2010) Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: Decreased memory B cells and membrane CD19 expression. Journal of Autoimmunity 34:4, 426-434
CrossRef53
Xiangyang Dong, Michelle V. Hoeltzle, John B. Hagan, Miguel A. Park, James T. Li, Roshini S. Abraham. (2010) Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B−A181E mutations in common variable immunodeficiency. Human Immunology 71:5, 505-511
CrossRef54
Annick A.J.M. van de Ven, Lisette van de Corput, Cornelis M. van Tilburg, Kiki Tesselaar, Rogier van Gent, Elisabeth A.M. Sanders, Marianne Boes, Andries C. Bloem, Joris M. van Montfrans. (2010) Lymphocyte characteristics in children with common variable immunodeficiency. Clinical Immunology 135:1, 63-71
CrossRef55
Nobuko Ishiura, Hiroko Nakashima, Rei Watanabe, Yoshihiro Kuwano, Takahiro Adachi, Yoshimasa Takahashi, Takeshi Tsubata, Hitoshi Okochi, Kunihiko Tamaki, Thomas F. Tedder, Manabu Fujimoto. (2010) Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation. European Journal of Immunology 40:4, 1192-1204
CrossRef56
Andre M. Vale, Harry W. Schroeder. (2010) Clinical consequences of defects in B-cell development. Journal of Allergy and Clinical Immunology 125:4, 778-787
CrossRef57
Menno C. van Zelm, Julie Smet, Brigitte Adams, Françoise Mascart, Liliane Schandené, Françoise Janssen, Alina Ferster, Chiung-Chi Kuo, Shoshana Levy, Jacques J.M. van Dongen, Mirjam van der Burg. (2010) CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. Journal of Clinical Investigation 120:4, 1265-1274
CrossRef58
Taco W. Kuijpers, Richard J. Bende, Paul A. Baars, Annette Grummels, Ingrid A.M. Derks, Koert M. Dolman, Tim Beaumont, Thomas F. Tedder, Carel J.M. van Noesel, Eric Eldering, René A.W. van Lier. (2010) CD20 deficiency in humans results in impaired T cell–independent antibody responses. Journal of Clinical Investigation 120:1, 214-222
CrossRef59
Katrina L Randall, Teresa Lambe, Andy Johnson, Bebhinn Treanor, Edyta Kucharska, Heather Domaschenz, Belinda Whittle, Lina E Tze, Anselm Enders, Tanya L Crockford, Tiphaine Bouriez-Jones, Duncan Alston, Jason G Cyster, Michael J Lenardo, Fabienne Mackay, Elissa K Deenick, Stuart G Tangye, Tyani D Chan, Tahra Camidge, Robert Brink, Carola G Vinuesa, Facundo D Batista, Richard J Cornall, Christopher C Goodnow. (2009) Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nature Immunology 10:12, 1283-1291
CrossRef60
Asghar Aghamohammadi, Nima Parvaneh, Nima Rezaei. (2009) Common variable immunodeficiency: a heterogeneous group needs further subclassification. Expert Review of Clinical Immunology 5:6, 629-631
CrossRef61
M. Sanyal, R. Fernandez, S. Levy. (2009) Enhanced B cell activation in the absence of CD81. International Immunology 21:11, 1225-1237
CrossRef62
Ömür Ardeniz, Charlotte Cunningham-Rundles. (2009) Granulomatous disease in common variable immunodeficiency. Clinical Immunology 133:2, 198-207
CrossRef63
Javad Mohammadi, Chonghai Liu, Asghar Aghamohammadi, Astrid Bergbreiter, Likun Du, Jiayi Lu, Nima Rezaei, Ali Akbar Amirzargar, Mostafa Moin, Ulrich Salzer, Qiang Pan-Hammarström, Lennart Hammarström. (2009) Novel Mutations in TACI (TNFRSF13B) Causing Common Variable Immunodeficiency. Journal of Clinical Immunology 29:6, 777-785
CrossRef64
Thomas F. Tedder. (2009) CD19: a promising B cell target for rheumatoid arthritis. Nature Reviews Rheumatology 5:10, 572-577
CrossRef65
Maja Hempel, Nuria Rivera Brugués, Janine Wagenstaller, Gaby Lederer, Andrea Weitensteiner, Heide Seidel, Thomas Meitinger, Tim M. Strom. (2009) Microdeletion syndrome 16p11.2-p12.2: Clinical and molecular characterization. American Journal of Medical Genetics Part A 149A:10, 2106-2112
CrossRef66
Shradha Agarwal, Lloyd Mayer. (2009) Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. Journal of Allergy and Clinical Immunology 124:4, 658-664
CrossRef67
Mary Ellen Conley. (2009) Genetics of hypogammaglobulinemia: what do we really know?. Current Opinion in Immunology 21:5, 466-471
CrossRef68
Sam Ahn, Charlotte Cunningham-Rundles. (2009) Role of B cells in common variable immune deficiency. Expert Review of Clinical Immunology 5:5, 557-564
CrossRef69
Stefan Feske. (2009) ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca 2+ entry in the immune system and beyond. Immunological Reviews 231:1, 189-209
CrossRef70
Shradha Agarwal, Charlotte Cunningham-Rundles. (2009) Autoimmunity in common variable immunodeficiency. Current Allergy and Asthma Reports 9:5, 347-352
CrossRef71
M. Hönig, J. Thiel, K. Warnatz, K. Schwarz. (2009) Angeborene Defekte der T- und B-Lymphozyten. Monatsschrift Kinderheilkunde 157:9, 853-860
CrossRef72
K. Warnatz, U. Salzer, M. Rizzi, B. Fischer, S. Gutenberger, J. Bohm, A.-K. Kienzler, Q. Pan-Hammarstrom, L. Hammarstrom, M. Rakhmanov, M. Schlesier, B. Grimbacher, H.-H. Peter, H. Eibel. (2009) B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proceedings of the National Academy of Sciences 106:33, 13945-13950
CrossRef73
Joyce E. Yu, Adina K. Knight, Lin Radigan, Thomas U. Marron, Li Zhang, Silvia Sanchez-Ramón, Charlotte Cunningham-Rundles. (2009) Toll-like receptor 7 and 9 defects in common variable immunodeficiency. Journal of Allergy and Clinical Immunology 124:2, 349-356.e3
CrossRef74
Stuart G. Tangye, David M. Tarlinton. (2009) Memory B cells: Effectors of long-lived immune responses. European Journal of Immunology 39:8, 2065-2075
CrossRef75
Drahomíra Detková, Teresa Español. (2009) An update on treatment strategies for common variable immunodeficiency. Expert Review of Clinical Immunology 5:4, 381-390
CrossRef76
KAROLINA BUKOWSKA-STRAKOVÁ, DANUTA KOWALCZYK, JAROSŁAW BARAN, MACIEJ SIEDLAR, KRZYSZTOF KOBYLARZ, MAREK ZEMBALA. (2009) The B-cell Compartment in the Peripheral Blood of Children With Different Types of Primary Humoral Immunodeficiency. Pediatric Research 66:1, 28-34
CrossRef77
Helen Chapel, Charlotte Cunningham-Rundles. (2009) Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. British Journal of Haematology 145:6, 709-727
CrossRef78
FRANCISCO A. BONILLA, RAIF S. GEHA. (2009) Common Variable Immunodeficiency. Pediatric Research 65:Supplement, 13R-19R
CrossRef79
Mary Ellen Conley, A. Kerry Dobbs, Dana M. Farmer, Sebnem Kilic, Kenneth Paris, Sofia Grigoriadou, Elaine Coustan-Smith, Vanessa Howard, Dario Campana. (2009) Primary B Cell Immunodeficiencies: Comparisons and Contrasts. Annual Review of Immunology 27:1, 199-227
CrossRef80
A. E. J. Poodt, G. J. A. Driessen, A. de Klein, J. J. M. van Dongen, M. van der Burg, E. de Vries. (2009) TACI mutations and disease susceptibility in patients with common variable immunodeficiency. Clinical & Experimental Immunology 156:1, 35-39
CrossRef81
Astrid Bergbreiter, Ulrich Salzer. (2009) Common variable immunodeficiency: a multifaceted and puzzling disorder. Expert Review of Clinical Immunology 5:2, 167-180
CrossRef82
U. Salzer, C. Bacchelli, S. Buckridge, Q. Pan-Hammarstrom, S. Jennings, V. Lougaris, A. Bergbreiter, T. Hagena, J. Birmelin, A. Plebani, A. D. B. Webster, H.-H. Peter, D. Suez, H. Chapel, A. McLean-Tooke, G. P. Spickett, S. Anover-Sombke, H. D. Ochs, S. Urschel, B. H. Belohradsky, S. Ugrinovic, D. S. Kumararatne, T. C. Lawrence, A. M. Holm, J. L. Franco, I. Schulze, P. Schneider, E. M. Gertz, A. A. Schaffer, L. Hammarstrom, A. J. Thrasher, H. B. Gaspar, B. Grimbacher. (2009) Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113:9, 1967-1976
CrossRef83
Guillaume Bussone, Luc Mouthon. (2009) Autoimmune manifestations in primary immune deficiencies. Autoimmunity Reviews 8:4, 332-336
CrossRef84
Tuba Turul, Ilhan Tezcan, Hasibe Artac, Sandra Bruin-Versteeg, Barbara H. Barendregt, Ismail Reisli, Ozden Sanal, Jacques J. M. Dongen, Mirjam Burg. (2009) Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. European Journal of Pediatrics 168:1, 87-93
CrossRef85
Joao B Oliveira, Luigi D Notarangelo, Thomas A Fleisher. (2008) Applications of flow cytometry for the study of primary immune deficiencies. Current Opinion in Allergy and Clinical Immunology 8:6, 499-509
CrossRef86
John J Lee, Esra Ozcan, Ingrid Rauter, Raif S Geha. (2008) Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Current Opinion in Allergy and Clinical Immunology 8:6, 520-526
CrossRef87
Patrick F.K. Yong, Ronnie Chee, Bodo Grimbacher. (2008) Hypogammaglobulinaemia. Immunology and Allergy Clinics of North America 28:4, 691-713
CrossRef88
Klaus Warnatz, Michael Schlesier. (2008) Flowcytometric phenotyping of common variable immunodeficiency. Cytometry Part B: Clinical Cytometry 74B:5, 261-271
CrossRef89
Silvia Sánchez-Ramón, Lin Radigan, Joyce E. Yu, Susan Bard, Charlotte Cunningham-Rundles. (2008) Memory B cells in common variable immunodeficiency: Clinical associations and sex differences. Clinical Immunology 128:3, 314-321
CrossRef90
Jean-Laurent Casanova, Claire Fieschi, Shen-Ying Zhang, Laurent Abel. (2008) Revisiting human primary immunodeficiencies. Journal of Internal Medicine 264:2, 115-127
CrossRef91
Miguel A Park, James T Li, John B Hagan, Daniel E Maddox, Roshini S Abraham. (2008) Common variable immunodeficiency: a new look at an old disease. The Lancet 372:9637, 489-502
CrossRef92
H. Chapel, M. Lucas, M. Lee, J. Bjorkander, D. Webster, B. Grimbacher, C. Fieschi, V. Thon, M. R. Abedi, L. Hammarstrom. (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112:2, 277-286
CrossRef93
Ignatius Chua, Isabella Quinti, Bodo Grimbacher. (2008) Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Current Opinion in Hematology 15:4, 368-374
CrossRef94
Peter D Arkwright, Mario Abinun. (2008) Recently identified factors predisposing children to infectious diseases. Current Opinion in Infectious Diseases 21:3, 217-222
CrossRef95
Eric Oksenhendler, Laurence Gérard, Claire Fieschi, Marion Malphettes, Gael Mouillot, Roland Jaussaud, Jean‐François Viallard, Martine Gardembas, Lionel Galicier, Nicolas Schleinitz, Felipe Suarez, Pauline Soulas‐Sprauel, Eric Hachulla, Arnaud Jaccard, Anaelle Gardeur, Ioannis Théodorou, Claire Rabian, Patrice Debré, . (2008) Infections in 252 Patients with Common Variable Immunodeficiency. Clinical Infectious Diseases 46:10, 1547-1554
CrossRef96
Patrick F.K. Yong, Michael Tarzi, Ignatius Chua, Bodo Grimbacher, Ronnie Chee. (2008) Common Variable Immunodeficiency: An Update on Etiology and Management. Immunology and Allergy Clinics of North America 28:2, 367-386
CrossRef97
Qiang Pan-Hammarström, Lennart Hammarström. (2008) Antibody deficiency diseases. European Journal of Immunology 38:2, 327-333
CrossRef98
Naomi TAKAHASHI, Tomohiro MORIO. (2008) Common variable immunodeficiency. Japanese Journal of Clinical Immunology 31:1, 9-16
CrossRef99
C. Wehr, T. Kivioja, C. Schmitt, B. Ferry, T. Witte, E. Eren, M. Vlkova, M. Hernandez, D. Detkova, P. R. Bos, G. Poerksen, H. von Bernuth, U. Baumann, S. Goldacker, S. Gutenberger, M. Schlesier, F. Bergeron-van der Cruyssen, M. Le Garff, P. Debre, R. Jacobs, J. Jones, E. Bateman, J. Litzman, P. M. van Hagen, A. Plebani, R. E. Schmidt, V. Thon, I. Quinti, T. Espanol, A. D. Webster, H. Chapel, M. Vihinen, E. Oksenhendler, H. H. Peter, K. Warnatz. (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111:1, 77-85
CrossRef100
Claudia Berek, Andreas Radbruch, Harry W. Schroeder. 2008. B-cell development and differentiation. , 113-125.
CrossRef101
Erik Glocker, Stephan Ehl, Bodo Grimbacher. (2007) Common variable immunodeficiency in children. Current Opinion in Pediatrics 19:6, 685-692
CrossRef102
Reinhold E. Schmidt. (2007) Primäre Immundefekte. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 50:12, 1502-1506
CrossRef103
H Kanegane, K Agematsu, T Futatani, M M Sira, K Suga, T Sekiguchi, M C van Zelm, T Miyawaki. (2007) Novel mutations in a Japanese patient with CD19 deficiency. Genes and Immunity 8:8, 663-670
CrossRef104
László Maródi, Luigi D. Notarangelo. (2007) Immunological and genetic bases of new primary immunodeficiencies. Nature Reviews Immunology 7:11, 851-861
CrossRef105
Wen-I Lee, Jing-Long Huang, Ming-Ling Kuo, Syh-Jae Lin, Li-Chen Chen, Mai-Tzu Chen, Tang-Her Jaing. (2007) Analysis of genetic defects in patients with the common variable immunodeficiency phenotype in a single Taiwanese tertiary care hospital. Annals of Allergy, Asthma & Immunology 99:5, 433-442
CrossRef106
Wagner A. Costa, Ricardo S. Cunha, Vera Lucia Bolzan, Andrea de Cássia R. Silva, Graciane Maria M. Caporale, Luciana B. Chaves, Gabriel W. Oselka, Dulce A. Junqueira, Maria Rosana I. Panachão, Ricardo A. Dias, Neide Y. Takaoka. (2007) Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium. Vaccine 25:48, 8140-8145
CrossRef107
Charlotte Cunningham-Rundles, Adina Kay Knight. (2007) Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunologic Research 38:1-3, 78-86
CrossRef108
Stefan Feske. (2007) Calcium signalling in lymphocyte activation and disease. Nature Reviews Immunology 7:9, 690-702
CrossRef109
S. Goldacker, R. Draeger, K. Warnatz, D. Huzly, U. Salzer, J. Thiel, H. Eibel, M. Schlesier, H.H. Peter. (2007) Active vaccination in patients with common variable immunodeficiency (CVID). Clinical Immunology 124:3, 294-303
CrossRef110
C. Bacchelli, S. Buckridge, A. J. Thrasher, H. B. Gaspar. (2007) Translational Mini-Review Series on Immunodeficiency:
Molecular defects in common variable immunodeficiency. Clinical & Experimental Immunology 149:3, 401-409
CrossRef111
O. Kopecký, Š. Lukešová. (2007) Genetic defects in common variable immunodeficiency. International Journal of Immunogenetics 34:4, 225-229
CrossRef112
Alejandro A Schäffer, Ulrich Salzer, Lennart Hammarström, Bodo Grimbacher. (2007) Deconstructing common variable immunodeficiency by genetic analysis. Current Opinion in Genetics & Development 17:3, 201-212
CrossRef113
G.M.P. Galbraith. (2007) An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene. Yearbook of Dermatology and Dermatologic Surgery 2007, 230-231
CrossRef114
Michael Borte, Bodo Grimbacher, Tim Niehues, Ellen Renner, Joachim Roesler, Volker Schuster. 2007. Immundefekte. , 667-706.
CrossRef115
Luigi D. Notarangelo, Alessandro Plebani, Evelina Mazzolari, Annarosa Soresina, Maria Pia Bondioni. (2007) Genetic Causes of Bronchiectasis: Primary Immune Deficiencies and the Lung. Respiration 74:3, 264-275
CrossRef116
Ömür Ardeniz, Sezgin Vatansever, Uğur Musabak, Kenan Aksu, Aytül Sin, Ali Kokuludağ. (2006) Arthritis as a presenting symptom in a hypogammaglobulinemic patient with thymectomy. Rheumatology International 27:3, 263-267
CrossRef117
Ulrich Salzer, Bodo Grimbacher. (2006) Common variable immunodeficiency: The power of co-stimulation. Seminars in Immunology 18:6, 337-346
CrossRef118
Michelle Hernandez, John F. Bastian. (2006) Immunodeficiency in childhood. Current Allergy and Asthma Reports 6:6, 468-474
CrossRef119
Rudd, Christopher E., . (2006) Disabled Receptor Signaling and New Primary Immunodeficiency Disorders. New England Journal of Medicine 354:18, 1874-1877
Full Text
